SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001387131-23-002065
Filing Date
2023-02-14
Accepted
2023-02-14 16:23:14
Documents
2
Group Members
ATLAS VENTURE ASSOCIATES OPPORTUNITY I, L.P.ATLAS VENTURE ASSOCIATES OPPORTUNITY I, LLCATLAS VENTURE ASSOCIATES OPPORTUNITY II, L.P.ATLAS VENTURE ASSOCIATES OPPORTUNITY II, LLCATLAS VENTURE ASSOCIATES XI, L.P.ATLAS VENTURE ASSOCIATES XI, LLCATLAS VENTURE

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM SC 13G dawn-sc13ga_123122.htm SC 13G/A 148854
2 JOINT FILING AGREEMENT ex-1.htm EX-1 22433
  Complete submission text file 0001387131-23-002065.txt   173386
Mailing Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Atlas Venture Fund XI, L.P. (Filed by) CIK: 0001708269 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Subject) CIK: 0001845337 (see all company filings)

IRS No.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92582 | Film No.: 23629862
SIC: 2834 Pharmaceutical Preparations